sacituzumab govitecan
gilead sciences
['bcsm', 'sacituzumab govitecan', 'breast']
sacituzumab govitecan demonstrates significant clinical benefit in hr+/her2- metastatic breast cancer #asco22 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.